secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-06-09T11:30:04+00:00
Accession:  0001140361-26-024560
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kuva Labs delays tender offer for Lisata to June 10; outside date extended to July 17
--------------------------------------------------------------------------------

- Tender offer commencement deadline extended from June 1 to June 10, 2026; company waives claims for previous delay.
- Outside date extended from July 1 to July 17, 2026; Parent may pay $1.5M non-refundable fee to extend to August 17.
- Parent acknowledges no committed financing; plans up to $25M in convertible notes from JBA Asset Management only non-binding.
- Company waives $250K interim operating payment default in exchange for $150K on June 12 and $100K on June 26.
- Lisata covenants not to sue until June 10; termination rights if Parent breaches.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126024560/0001140361-26-024560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126024560/ef20075787_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-024560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer